Funding Opportunities

• Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01)
  (PA-17-196)
  National Institute on Drug Abuse
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R21)
  (PA-17-197)
  National Institute on Drug Abuse
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03)
  (PA-17-198)
  National Institute on Drug Abuse
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Hearing Health Care for Adults: Improving Access and Affordability (R01)
  (PA-17-202)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Nutrition and Alcohol-Related Health Outcomes (R01)
  (PA-17-211)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Nutrition and Alcohol-Related Health Outcomes (R03)
  (PA-17-212)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 16, 2017.
• Nutrition and Alcohol-Related Health Outcomes (R21)
  (PA-17-213)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24)
  (PAR-17-172)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): New Applications: October 6, 2017, June 7, 2018; February 7, 2019; and October 7, 2019 Resubmission and Revision Applications: June 21, 2018, February 21, 2019, and October 21, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (U24)
  (PAR-17-173)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): February 2, 2018; October 3, 2018; May 31, 2019; and January 31, 2020 Resubmission and Revision Applications: February 14, 2018; October 17, 2018; June 14, 2019; and February 14, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3)
  (PAR-17-174)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): New Applications: October 6, 2017 June 7, 2018; February 7, 2019; and October 7, 2019 Resubmission and revision Applications: June 21, 2018; February 21, 2019; and October 21, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3)
  (PAR-17-175)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): New Applications: February 2, 2018; October 3, 2018; May 31, 2019; and January 31, 2020 Resubmission and Revision Applications: February 14, 2018; October 17, 2018; June 14, 2019; and February 14, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)
  (PAR-17-201)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): August 9, 2017, Feb 6, 2018, Aug 9, 2018, Feb 9, 2019, August 9, 2019, Feb 11, 2020 , by 5:00 PM local time of applicant organization.
• Inter-organelle Communication in Cancer (R01)
  (PAR-17-203)
  National Cancer Institute
  Application Receipt Date(s): August 16, 2017; January 17, 2018; August 15, 2018; January 16, 2019; August 14, 2019; January 15, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Inter-organelle Communication in Cancer (R21)
  (PAR-17-204)
  National Cancer Institute
  Application Receipt Date(s): August 16, 2017, January 17, 2018; August 15, 2018; January 16, 2019; August 14, 2019; January 15, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3)
  (PAR-17-205)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  NIH Blueprint for Neuroscience Research
  Application Receipt Date(s): August 9, 2017, Feb 7, 2018, Aug 9, 2018, Feb 9, 2019, August 9, 2019, Feb 11, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01)
  (PAR-17-206)
  National Cancer Institute
  Application Receipt Date(s): June 8 2017; February 7, 2018; June 8, 2018; February 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratories (U01)
  (PAR-17-207)
  National Cancer Institute
  Application Receipt Date(s): June 8, 2017; February 7, 2018; June 8, 2018; February 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30)
  (PAR-17-208)
  National Institute of General Medical Sciences
  Application Receipt Date(s): May 26, 2017; May 28, 2018; and May 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Research Education: Bridges to the Doctorate (R25)
  (PAR-17-209)
  National Institute of General Medical Sciences
  Application Receipt Date(s): September 25, 2017; September 25, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Bridges to the Baccalaureate Program (R25)
  (PAR-17-210)
  National Institute of General Medical Sciences
  Application Receipt Date(s): September 25, 2017; September 25, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition: Analysis of Data from NIA's Alzheimer's Disease Sequencing Project Follow-Up Study (U01)
  (PAR-17-214)
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 5, 2017.
• NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01)
  (PAR-17-215)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): New Applications: June 2, 2017; October 3, 2017; February 2, 2018; June 1, 2018; October 3, 2018; February 1, 2019; May 31, 2019; October 3, 2019; and January 31, 2020 Resubmission, Revision, and Renewal Applications: October 18, 2017, February 20, 2018, June 14, 2018, October 17, 2018, February 15, 2019, June 14, 2019, October 17, 2019, February 14, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NCCIH Natural Product Phase II Clinical Trial Cooperative Agreement (U01)
  (PAR-17-216)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): New Applications: June 7, 2017; October 6, 2017; June 7, 2018; February 7, 2019; and October 8, 2019 Resubmission, Revision, and Renewal Applications: October 20, 2017; June 21, 2018; February 21, 2019; and October 21, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Alcohol-PTSD Comorbidity: Preclinical Studies of Models and Mechanisms (R01)
  (RFA-AA-17-016)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): May 17, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1)
  (RFA-DA-18-001)
  National Institute on Drug Abuse
  Application Receipt Date(s): July 31, 2017, July 31, 2018, July 31, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on .
• NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3)
  (RFA-DA-18-003)
  National Institute on Drug Abuse
  Application Receipt Date(s): July 25 2017; July 25, 2018; July 25, 2019; by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and in Health Disparities Populations (UG3/UH3)
  (RFA-NS-17-012)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): May 9, 2017 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.